TEST BANK kk
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
kk kk kk kk kk kk kk
Author: Teri Moser Woo and Wendy L. Wright
kk kk kk kk kk kk kk
, TABLE OF CONTENT kk kk
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ....................................................................... 4
kk kk kk kk kk kk kk kk kk kk
Chapter 2. Review of Basic Principles of Pharmacology ....................................................................................... 5
kk kk kk kk kk kk kk
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
kk kk kk kk
Chapter 4. Legal and Professional Issues in Prescribing ...................................................................................... 14
kk kk kk kk kk kk kk
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
kk kk kk kk
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
kk kk kk kk kk
Chapter 7. Nutrition and Nutraceuticals............................................................................................................... 22
kk kk kk kk
Chapter 8. Herbal Therapies ................................................................................................................................ 28
kk kk kk
Chapter 9. Cannabis ............................................................................................................................................. 31
kk kk
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
kk kk
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................ 38
kk kk kk kk kk kk kk
Chapter 12. Drugs Affecting the Central Nervous System................................................................................... 45
kk kk kk kk kk kk kk
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................. 53
kk kk kk kk kk kk kk kk
Chapter 14. Drugs Affecting the Respiratory System .......................................................................................... 61
kk kk kk kk kk kk
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
kk kk kk kk kk kk
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................... 69
kk kk kk kk kk kk kk kk kk
Chapter 17. Drugs Affecting the Immune System: Immunomodulators .............................................................. 75
kk kk kk kk kk kk kk
Chapter 18. Drugs Affecting the Gastrointestinal System.................................................................................... 77
kk kk kk kk kk kk
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ...................... 80
kk kk kk kk kk kk kk kk kk kk kk
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs .............................. 83
kk kk kk kk kk kk kk kk kk kk kk
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
kk kk kk kk kk kk
Chapter 22. Drugs Affecting the Bones and Joints............................................................................................... 92
kk kk kk kk kk kk kk
Chapter 23. Drugs Affecting the Integumentary System...................................................................................... 96
kk kk kk kk kk kk
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................ 101
kk kk kk kk kk kk kk
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ......................................................... 105
kk kk kk kk kk kk kk kk kk kk
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................. 108
kk kk kk kk kk kk kk
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ................................................................................... 111
kk kk kk kk kk kk kk kk kk
Chapter 28. Anemia ........................................................................................................................................... 113
kk kk
Chapter 29. Anxiety and Depression ................................................................................................................. 116
kk kk kk kk
Chapter 30. Attention Deficit-Hyperactivity Disorder....................................................................................... 120
kk kk kk kk
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
kk kk kk kk
Chapter 32. Chronic Obstructive Pulmonary Disease ........................................................................................ 125
kk kk kk kk kk
Chapter 33. Contraception ................................................................................................................................. 127
kk kk
Chapter 34. COVID-19: Acute and Chronic ...................................................................................................... 130
kk kk kk kk kk
Chapter 35. Dermatological Conditions............................................................................................................. 134
kk kk kk
Chapter 36. Diabetes Management .................................................................................................................... 138
kk kk kk
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ....................................................................... 146
kk kk kk kk kk kk kk
Chapter 38. Headaches ...................................................................................................................................... 149
kk kk
Chapter 39. Heart Failure................................................................................................................................... 153
kk kk kk
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................. 158
kk kk kk kk kk kk kk
Chapter 41. Menopausal Hormone Therapy ...................................................................................................... 161
kk kk kk kk
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
kk kk
Chapter 43. Hypertension .................................................................................................................................. 169
kk kk
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
kk kk kk kk
Chapter 45. Obesity ........................................................................................................................................... 177
kk kk
Chapter 46. Pain Management: Acute and Chronic Pain ................................................................................... 181
kk kk kk kk kk kk kk
Chapter 47. Pneumonia ...................................................................................................................................... 185
kk kk
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................. 187
kk kk kk kk kk kk
Chapter 49. Substance Use Disorders ................................................................................................................ 190
kk kk kk kk
Chapter 50. Tuberculosis ................................................................................................................................... 195
kk kk
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............. 197
kk kk kk kk kk kk kk kk kk kk kk kk
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
kk kk kk kk
Chapter 53. Women as Patients ......................................................................................................................... 203
kk kk kk kk
Chapter 54. Men as Patients ............................................................................................................................... 207
kk kk kk kk
Chapter 55. Pediatric Patients ............................................................................................................................ 209
kk kk kk
Chapter 57. Geriatric Patients ............................................................................................................................ 213
kk kk kk
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e kk kk kk kk Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
kk kk kk kk kk kk kk kk kk kk
MULTIPLE CHOICE kk
1. Nurse practitioner prescriptive authority is regulated by:
kk kk kk kk kk kk
A. The National Council of State Boards of Nursing
kk kk kk kk kk kk kk
B. The U.S. Drug Enforcement Administration
kk kk kk kk
C. The State Board of Nursing for each state
kk kk kk kk kk kk kk
D. The State Board of Pharmacy kk kk kk kk
ANS: k k C PTS: k k k k 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
kk kk kk kk kk kk kk kk kk kk kk kk kk
kkinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
kk kk kk kk kk kk kk kk kk kk kk
both in their basic nursing program and in their APRN program.
kk kk kk kk kk kk kk kk kk kk kk
B. Nurses care for the patient from a holistic approach and include the patient in
kk kk kk kk kk kk kk kk kk kk kk kk kk
decision-making regarding their care.
kk kk kk kk
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
kk kk kk kk kk kk kk kk kk k
D. APRNs are able to prescribe independently in all states, whereas a physician’s
kk kk kk kk kk kk kk kk kk kk kk
assistant needs to have a physician supervising their practice.
kk kk kk kk kk kk kk kk kk
ANS: k k B PTS: k k k k 1
3. Clinical judgment in prescribing includes:
kk kk kk kk
A. Factoring in the cost to the patient of the medication prescribed kk kk kk kk kk kk kk kk kk kk
B. Always prescribing the newest medication available for the disease process
kk kk kk kk kk kk kk kk k
C. Handing out drug samples to poor patients kk kk kk kk kk kk
D. Prescribing all generic medications to cut costs kk kk kk kk kk kk
ANS: k k A PTS: k k k k 1
4. The process for choosing an effective drug for a disorder includes:
kk kk kk kk kk kk kk kk kk kk
A. Asking the patient what drug they think would work best for them
kk kk kk kk kk kk kk kk kk kk kk
B. Consulting nationally recognized guidelines for diseasemanagement kk kk kk kk kk k
C. Prescribing medications that are available as samples before writing a prescription kk kk kk kk kk kk kk kk kk kk
D. Following U.S. Drug Enforcement Administration guidelines forprescribing kk kk kk kk kk kk k
ANS: k k B PTS: k k k k 1
5. Nonintentional nonadherence of drug therapy may occur due to: kk kk kk kk kk kk kk kk
A. Belief that medication does not work kk kk kk kk kk
B. Adverse drug reactions kk kk
C. Chronic conditions that require daily therapy kk kk kk kk kk
D. Forgetfulness or distraction kk k
ANS: k k D PTS: k k k k 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
kk kk kk kk kk kk kk
Author: Teri Moser Woo and Wendy L. Wright
kk kk kk kk kk kk kk
, TABLE OF CONTENT kk kk
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ....................................................................... 4
kk kk kk kk kk kk kk kk kk kk
Chapter 2. Review of Basic Principles of Pharmacology ....................................................................................... 5
kk kk kk kk kk kk kk
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
kk kk kk kk
Chapter 4. Legal and Professional Issues in Prescribing ...................................................................................... 14
kk kk kk kk kk kk kk
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
kk kk kk kk
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
kk kk kk kk kk
Chapter 7. Nutrition and Nutraceuticals............................................................................................................... 22
kk kk kk kk
Chapter 8. Herbal Therapies ................................................................................................................................ 28
kk kk kk
Chapter 9. Cannabis ............................................................................................................................................. 31
kk kk
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
kk kk
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................ 38
kk kk kk kk kk kk kk
Chapter 12. Drugs Affecting the Central Nervous System................................................................................... 45
kk kk kk kk kk kk kk
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................. 53
kk kk kk kk kk kk kk kk
Chapter 14. Drugs Affecting the Respiratory System .......................................................................................... 61
kk kk kk kk kk kk
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
kk kk kk kk kk kk
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................... 69
kk kk kk kk kk kk kk kk kk
Chapter 17. Drugs Affecting the Immune System: Immunomodulators .............................................................. 75
kk kk kk kk kk kk kk
Chapter 18. Drugs Affecting the Gastrointestinal System.................................................................................... 77
kk kk kk kk kk kk
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ...................... 80
kk kk kk kk kk kk kk kk kk kk kk
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs .............................. 83
kk kk kk kk kk kk kk kk kk kk kk
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
kk kk kk kk kk kk
Chapter 22. Drugs Affecting the Bones and Joints............................................................................................... 92
kk kk kk kk kk kk kk
Chapter 23. Drugs Affecting the Integumentary System...................................................................................... 96
kk kk kk kk kk kk
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................ 101
kk kk kk kk kk kk kk
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ......................................................... 105
kk kk kk kk kk kk kk kk kk kk
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................. 108
kk kk kk kk kk kk kk
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ................................................................................... 111
kk kk kk kk kk kk kk kk kk
Chapter 28. Anemia ........................................................................................................................................... 113
kk kk
Chapter 29. Anxiety and Depression ................................................................................................................. 116
kk kk kk kk
Chapter 30. Attention Deficit-Hyperactivity Disorder....................................................................................... 120
kk kk kk kk
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
kk kk kk kk
Chapter 32. Chronic Obstructive Pulmonary Disease ........................................................................................ 125
kk kk kk kk kk
Chapter 33. Contraception ................................................................................................................................. 127
kk kk
Chapter 34. COVID-19: Acute and Chronic ...................................................................................................... 130
kk kk kk kk kk
Chapter 35. Dermatological Conditions............................................................................................................. 134
kk kk kk
Chapter 36. Diabetes Management .................................................................................................................... 138
kk kk kk
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ....................................................................... 146
kk kk kk kk kk kk kk
Chapter 38. Headaches ...................................................................................................................................... 149
kk kk
Chapter 39. Heart Failure................................................................................................................................... 153
kk kk kk
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................. 158
kk kk kk kk kk kk kk
Chapter 41. Menopausal Hormone Therapy ...................................................................................................... 161
kk kk kk kk
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
kk kk
Chapter 43. Hypertension .................................................................................................................................. 169
kk kk
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
kk kk kk kk
Chapter 45. Obesity ........................................................................................................................................... 177
kk kk
Chapter 46. Pain Management: Acute and Chronic Pain ................................................................................... 181
kk kk kk kk kk kk kk
Chapter 47. Pneumonia ...................................................................................................................................... 185
kk kk
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................. 187
kk kk kk kk kk kk
Chapter 49. Substance Use Disorders ................................................................................................................ 190
kk kk kk kk
Chapter 50. Tuberculosis ................................................................................................................................... 195
kk kk
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............. 197
kk kk kk kk kk kk kk kk kk kk kk kk
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
kk kk kk kk
Chapter 53. Women as Patients ......................................................................................................................... 203
kk kk kk kk
Chapter 54. Men as Patients ............................................................................................................................... 207
kk kk kk kk
Chapter 55. Pediatric Patients ............................................................................................................................ 209
kk kk kk
Chapter 57. Geriatric Patients ............................................................................................................................ 213
kk kk kk
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e kk kk kk kk Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
kk kk kk kk kk kk kk kk kk kk
MULTIPLE CHOICE kk
1. Nurse practitioner prescriptive authority is regulated by:
kk kk kk kk kk kk
A. The National Council of State Boards of Nursing
kk kk kk kk kk kk kk
B. The U.S. Drug Enforcement Administration
kk kk kk kk
C. The State Board of Nursing for each state
kk kk kk kk kk kk kk
D. The State Board of Pharmacy kk kk kk kk
ANS: k k C PTS: k k k k 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
kk kk kk kk kk kk kk kk kk kk kk kk kk
kkinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
kk kk kk kk kk kk kk kk kk kk kk
both in their basic nursing program and in their APRN program.
kk kk kk kk kk kk kk kk kk kk kk
B. Nurses care for the patient from a holistic approach and include the patient in
kk kk kk kk kk kk kk kk kk kk kk kk kk
decision-making regarding their care.
kk kk kk kk
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
kk kk kk kk kk kk kk kk kk k
D. APRNs are able to prescribe independently in all states, whereas a physician’s
kk kk kk kk kk kk kk kk kk kk kk
assistant needs to have a physician supervising their practice.
kk kk kk kk kk kk kk kk kk
ANS: k k B PTS: k k k k 1
3. Clinical judgment in prescribing includes:
kk kk kk kk
A. Factoring in the cost to the patient of the medication prescribed kk kk kk kk kk kk kk kk kk kk
B. Always prescribing the newest medication available for the disease process
kk kk kk kk kk kk kk kk k
C. Handing out drug samples to poor patients kk kk kk kk kk kk
D. Prescribing all generic medications to cut costs kk kk kk kk kk kk
ANS: k k A PTS: k k k k 1
4. The process for choosing an effective drug for a disorder includes:
kk kk kk kk kk kk kk kk kk kk
A. Asking the patient what drug they think would work best for them
kk kk kk kk kk kk kk kk kk kk kk
B. Consulting nationally recognized guidelines for diseasemanagement kk kk kk kk kk k
C. Prescribing medications that are available as samples before writing a prescription kk kk kk kk kk kk kk kk kk kk
D. Following U.S. Drug Enforcement Administration guidelines forprescribing kk kk kk kk kk kk k
ANS: k k B PTS: k k k k 1
5. Nonintentional nonadherence of drug therapy may occur due to: kk kk kk kk kk kk kk kk
A. Belief that medication does not work kk kk kk kk kk
B. Adverse drug reactions kk kk
C. Chronic conditions that require daily therapy kk kk kk kk kk
D. Forgetfulness or distraction kk k
ANS: k k D PTS: k k k k 1
